0001437749-23-012870.txt : 20230505 0001437749-23-012870.hdr.sgml : 20230505 20230505193542 ACCESSION NUMBER: 0001437749-23-012870 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230504 FILED AS OF DATE: 20230505 DATE AS OF CHANGE: 20230505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Steinhart Richard I CENTRAL INDEX KEY: 0001293789 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 23895524 MAIL ADDRESS: STREET 1: 125 ELM STREET CITY: NEW CANAAN STATE: CT ZIP: 06840 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: ATOSSA GENETICS INC DATE OF NAME CHANGE: 20100325 4 1 rdgdoc.xml FORM 4 X0407 4 2023-05-04 0001488039 ATOSSA THERAPEUTICS, INC. ATOS 0001293789 Steinhart Richard I C/O ATOSSA THERAPEUTICS, INC., 107 SPRING STREET SEATTLE WA 98104 1 0 Stock Option (right to buy) 0.662 2023-05-04 4 A 0 125000 0 A 2033-05-04 Common Stock 125000 125000 D The options shall vest on a quarterly basis over the next 12 months. The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023. /s/ Richard I. Steinhart 2023-05-05